ARTICLE | Company News
Afinitor sales and marketing update
November 17, 2016 10:46 PM UTC
The U.K.'s NICE issued a final appraisal determination (FAD) recommending the use of Afinitor everolimus from Novartis in combination with exemestane to treat advanced EGFR2 (HER2; ErbB2; neu)-negativ...
BCIQ Company Profiles